Authors: | Passaro, A.; Yu, H. A.; Nguyen, D.; Lee, V. H. F.; Soo, R. A.; Kim, S. H.; Daga, H.; Tan, D. S. W.; Kim, S. W.; Juan Vidal, O. J.; Piotrowska, Z.; Keeton, E. K.; Liu, T.; Li, S.; Jones, J.; Ruiter, G. |
Abstract Title: | Safety and anti-tumour activity of zipalertinib in NSCLC patients (pts) with EGFR exon 20 insertion (ex20ins) mutations who received prior amivantamab |
Meeting Title: | ESMO Congress 2024 |
Journal Title: | Annals of Oncology |
Volume: | 35 |
Issue: | Suppl. 2 |
Meeting Dates: | 2024 Sep 13-17 |
Meeting Location: | Barcelona, Spain |
ISSN: | 0923-7534 |
Publisher: | Oxford University Press |
Date Published: | 2024-09-01 |
Start Page: | S803 |
End Page: | S804 |
Language: | English |
ACCESSION: | WOS:001326612901557 |
DOI: | 10.1016/j.annonc.2024.08.1311 |
PROVIDER: | wos |
Notes: | Meeting Abstract: 1254MO -- Source: Wos |